71 results
20FR12B
EX-4.23
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
, social or pension payments or deductions, salaries or wages of any kind, stock options, any advanced notice or pay in lieu thereof, overtime payment … limitation, for travel, recreation pay, vacation pay or redemption of such, sick pay or payment for sick days not utilized, any payment and/or social
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Mar 13
Current report (foreign)
12:00am
– Consistent timing
– Social cognition test
Next Steps
Discontinue CLARITY study
– No additional patients will be enrolled in the trial
Perform complete
F-1
EX-10.21
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
a component of Employee’s Salary, including with regard to social benefits and/or any other right to which Employee is entitled by virtue
20FR12B
EX-4.20
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
a component of Employee’s Salary, including with regard to social benefits and/or any other right to which Employee is entitled by virtue
6-K
EX-1
BLRX
Bioline Rx Ltd
11 Jun 14
Current report (foreign)
12:00am
to food contamination with gluten, as well as eating habits in a social setting.
About BioLineRx
BioLineRx is a publicly-traded, clinical-stage
6-K
EX-99
51z0e9w5va1jau2zf13o
21 Aug 14
BioLineRx Receives Notice of Allowance for US Patent on BL-7010
12:00am
F-1
EX-10.2
20sl1zut1 ayy02r0t3
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.2
946w91 qowj9
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.3
jbv mgvz0g
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.3
fuieizp6iypeytr
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
bbizy ygmasorjlcivl
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
9ibiq2uh 3y1a21i
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
tkncihs1
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
6-K
EX-99
n3t8lmr4lcd0
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
6-K
EX-99
9dtfubi7s5h356nsk3
10 Mar 14
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study
12:00am
6-K
EX-99
m48dgscfrnvnvjkb
16 Jul 14
BioLineRx Announces Results from
12:00am
6-K
EX-99
6w9tp 1n1
5 Nov 14
BioLineRx Announces Successful Final Results of
12:00am
F-1
EX-10.22
pw64 vrnsc
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.21
txz5ei8ojiznw t7
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.5
jpeh9xk
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am